[1]
S. BHAVADHARANI, A. VISWANATHAN, N. BRAHMA, V. S, and D. T. PUGAZHENDHI, “ATORVASTATIN IN CEREBRAL CAVERNOUS MALFORMATION: ELUCIDATING ROCK INHIBITION AND LIPID-LOWERING MECHANISMS FOR THERAPEUTIC REPURPOSING”, TPM, vol. 32, no. S1 (2025): Posted 12 May, pp. 396–399, Aug. 2025.